Brain Research Center

Brain Research Center is a Netherlands-based, for-profit clinical drug research organization focused on brain diseases, especially Alzheimer's disease, Parkinson's disease, mild cognitive impairment, and related dementias. Founded in 2009 out of Amsterdam UMC, it operates full-service research centers in Amsterdam, Den Bosch, and Zwolle and acts as a link between patients, medical specialists, and pharmaceutical and biotech sponsors. The organization provides trial execution, study start-up, and consultancy services for neurology-focused clinical studies, and also supports use of the Amsterdam IADL Questionnaire as an outcome measure. Its visible study portfolio includes sponsor-led interventional trials involving candidates such as PRI-002, efavirenz, BIIB080, and BIIB122. Brain Research Center is best characterized as a specialized neuroscience clinical trial site network rather than a therapeutic product developer.